Jin-Lan Huang

Dr. Jin-Lan Huang

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 November 2022 in The Journal of Pathology
Verified
Journal Article
Closed access
DWDeng‐Pan Wu
Deng‐Pan Wu
YZYuan‐Dan Zhao
Yuan‐Dan Zhao
QYQiu‐Qing Yan
Qiu‐Qing Yan
LLLing‐Ling Liu
Ling‐Ling Liu
YWYan‐Su Wei
Yan‐Su Wei
JHJin-Lan Huang
Jin-Lan Huang

30 January 2017 in Evidence-Based Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
JHJin-Lan Huang
Jin-Lan Huang
XJXin Jing
Xin Jing
XTXin Tian
Xin Tian
MQMei-Chun Qin
Mei-Chun Qin
ZXZhe-Hao Xu
Zhe-Hao Xu
ZZZhen Guo Zhong
Zhen Guo Zhong
Inhibiting oxidative damage in early stage of Alzheimer’s disease (AD) is considered as a strategy for AD treatment. Our previous study has shown that Panax notoginseng saponins (PNS) have an antiaging action by increasing the levels of superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GSH‐PX) in the serum of aged rats. In this study, we aimed to investigate the effects of PNS on antioxidant enzymes and uncoupling proteins (UCPs) involved in oxidative stress in AD mice. The results showed that PNS prevented neuronal loss in hippocampal CA1 region and alleviated pathomorphological change of neurons in CA1 region. Moreover, PNS inhibited the production of 8‐hydroxydeoxyguanosine (8‐OHdG), enhanced the expressions and activities of SOD, CAT, and GSH‐PX, and improved the mRNA and protein levels of UCP4 and UCP5 in the brains of SAMP8 mice. Together, our study shows that PNS has the ability to protect neurons in AD brain from oxidative stress damage through attenuating the production of 8‐OHdG, enhancing the activities of antioxidant enzymes and the expressions levels of UCP4 and UCP5. Accordingly, PNS may be a promising agent for AD treatment.

7 August 2021 in Aging Cell
Verified
Journal Article
Open access
PDF file
JHJin-Lan Huang
Jin-Lan Huang
FZFan Zhang
Fan Zhang
MSMin Su
Min Su
JLJiaxin Li
Jiaxin Li
WYWen Yi
Wen Yi
DWDeng-Pan Wu
Deng-Pan Wu
Age‐related cognitive decline in neurodegenerative diseases, such as Alzheimer's disease (AD), is associated with the deficits of synaptic plasticity. Therefore, exploring promising targets to enhance synaptic plasticity in neurodegenerative disorders is crucial. It has been demonstrated that methyl‐CpG binding protein 2 (MeCP2) plays a vital role in neuronal development and MeCP2 malfunction causes various neurodevelopmental disorders. However, the role of MeCP2 in neurodegenerative diseases has been less reported. In the study, we found that MeCP2 expression in the hippocampus was reduced in the hippocampus of senescence‐accelerated mice P8 (SAMP8) mice. Overexpression of hippocampal MeCP2 could elevate synaptic plasticity and cognitive function in SAMP8 mice, while knockdown of MeCP2 impaired synaptic plasticity and cognitive function in senescence accelerated‐resistant 1 (SAMR1) mice. MeCP2‐mediated regulation of synaptic plasticity may be associated with CREB1 pathway. These results suggest that MeCP2 plays a vital role in age‐related cognitive decline by regulating synaptic plasticity and indicate that MeCP2 may be promising targets for the treatment of age‐related cognitive decline in neurodegenerative diseases.

14 February 2025 in Alzheimer's Research & Therapy
Verified
Journal Article
Open access
PDF file
DWDeng-Pan Wu
Deng-Pan Wu
YWYan-Su Wei
Yan-Su Wei
LHLi-Xiang Hou
Li-Xiang Hou
YDYu-Xuan Du
Yu-Xuan Du
QYQiu-Qing Yan
Qiu-Qing Yan
JHJin-Lan Huang
Jin-Lan Huang
Background: Abnormal microglial polarization phenotypes contribute to the pathogenesis of Alzheimer’s disease (AD). Circular RNAs (circRNAs) have garnered increasing attention due to their significant roles in human diseases. Although research has demonstrated differential expression of circRNAs in AD, their specific functions in AD pathogenesis remain largely unexplored. Methods: CircRNA microarray was performed to identify differentially expressed circRNAs in the hippocampus of APP/PS1 and WT mice. The stability of circAPP was assessed via RNase R treatment assay. CircAPP downstream targets miR-1906 and chloride intracellular channel 1 (CLIC1) were identified using bioinformatics and proteomics, respectively. RT-PCR assay was conducted to detect the expression of circAPP, miR-1906 and CLIC1. Morris water maze (MWM) test, passive avoidance test and novel object recognition task were used to detect cognitive function of APP/PS1 mice. Microglial M1/M2 polarization and AD pathology were assessed using Western blot, flow cytometry and Golgi staining assays. CLIC1 expression and channel activity were evaluated using Western blot and functional chloride channel assays, respectively. The subcellular location of circAPP was assessed via FISH and RT-PCR assays. RNA pull-down assay was performed to detect the interaction of miR-1906 with circAPP and 3’ untranslated region (3’UTR) of CLIC1 mRNA. Results: In this study, we identified a novel circRNA, named circAPP, that is encoded by amyloid precursor protein (APP) and is implicated in AD. CircAPP is a stable circRNA that was upregulated in Aβ-treated microglial cells and the hippocampus of APP/PS1 mice. Downregulation of circAPP or CLIC1, or overexpression of miR-1906 in microglia modulated microglial M1/M2 polarization in Aβ-treated microglial cells and the hippocampus of APP/PS1 mice, and improved AD pathology and the cognitive function of APP/PS1 mice. Further results revealed that circAPP was mainly distributed in the cytoplasm, and circAPP could regulate CLIC1 expression and channel activity by interacting with miR-1906 and affecting miR-1906 expression, thereby regulating microglial polarization in AD. Conclusions: Taken together, our study elucidates the regulatory role of circAPP in AD microglial polarization via miR-1906/CLIC1 axis, and suggests that circAPP may act as a critical player in AD pathogenesis and represent a promising therapeutic target for AD.

1 January 2019 in International Journal of Biological Sciences
Verified
Journal Article
Open access
DWDeng-Pan Wu
Deng-Pan Wu
LBLi-Ru Bai
Li-Ru Bai
YLYan-Fang Lv
Yan-Fang Lv
YZYan Zhou
Yan Zhou
CDChun-Hui Ding
Chun-Hui Ding
JHJin-Lan Huang
Jin-Lan Huang
In spite of initially promising responses, 5-year recurrence after photodynamic therapy (PDT) sustains high level and an increase in PDT effectiveness is needed. It has been demonstrated that gap junctional intercellular communication (GJIC) formed by Connexin (Cx)43 could improve the transfer of “death signal” between cells, thereby causing the enhancement of cytotoxicity of chemotherapeutics and suicide gene therapy. Nevertheless, whether Cx43-composed GJIC has an effect on PDT phototoxicity remains unknown. This study showed that Cx43-formed GJIC could improve PDT phototoxicity to tumor cells in vitro and in vivo. Specifically, Cx43-formed GJIC under the condition of high cellular density could improve PDT phototoxicity in Cx43-transfected HeLa cells and Cx43-expressing U87 glioma cells. This effect was remarkably inhibited when Cx43 was not expressed or Cx43-formed GJ channels were prohibited. Additionally, the presence of Cx43-mediated GJIC could decrease the mean RTV and tumor weights of xenografts after Photofrin-PDT. The improved PDT efficacy by Cx43-composed GJIC was correlated with stress signaling pathways mediated by ROS, calcium and lipid peroxide. The present study demonstrates the presence of Cx43-composed GJIC improves PDT phototoxicity and suggests that therapeutic strategies designed to upregulate the expression of Cx43 or enhance Cx43-mediated GJIC function may increase the sensitivity of malignant cell to PDT, leading to the increment of PDT efficacy. Oppositely, factors that retard Cx43 expression or prohibit the function of Cx43-mediated GJIC may cause insensitivity of malignant cells to PDT, leading to PDT resistance.

13 December 2023 in Molecular Neurobiology
Verified
Journal Article
Closed access
PDF file
DWDeng-Pan Wu
Deng-Pan Wu
WYWen Yi
Wen Yi
YZYuan-Dan Zhao
Yuan-Dan Zhao
YWYan-Su Wei
Yan-Su Wei
LLLing-Ling Liu
Ling-Ling Liu
JHJin-Lan Huang
Jin-Lan Huang